Screening Questionnaire for Depression

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2008 by Sheba Medical Center.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Sheba Medical Center
ClinicalTrials.gov Identifier:
NCT00480233
First received: May 29, 2007
Last updated: February 4, 2008
Last verified: February 2008
  Purpose

Depression is common in primary care and general medical settings, but is often unrecognized and untreated by physicians working in those settings.

The Patient Health Questionnaire for depression (PHQ-9) is well validated and widely used screening instrument.


Condition
Depression

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Validation of a Hebrew Version of a Brief Screening Questionnaire for Depression in General Medicine

Further study details as provided by Sheba Medical Center:

Estimated Enrollment: 200
Study Start Date: January 2008
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Primary care and general medical patients

Criteria

Inclusion Criteria:

  • >18 yrs
  • Primary care and general medical patients
  • Understand the IC
  • Speaks Hebrew
  • No significant cognitive impairment
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00480233

Contacts
Contact: Raz Gross, MD, MPH razg@gertner.health.gov.il

Locations
Israel
Sheba Medical Center and Maccabi Health Services Recruiting
Tel Hashomer, Israel
Contact: Galit Geulayov    972-3-5305180    galitg@gertner.health.gov.il   
Principal Investigator: Raz Gross, MD, MPH         
Sub-Investigator: Galit Geulayov         
Sponsors and Collaborators
Sheba Medical Center
Investigators
Principal Investigator: Raz Gross, MD, MPH The Gertner Institute for Epidemiology and Health Policy Research
  More Information

No publications provided

Responsible Party: Raz Gross, Head, Mental Health Epidemiology, The Gertner Institute for Epidemiology
ClinicalTrials.gov Identifier: NCT00480233     History of Changes
Other Study ID Numbers: SHEBA-06-4420-RG-CTRL
Study First Received: May 29, 2007
Last Updated: February 4, 2008
Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration

Keywords provided by Sheba Medical Center:
depression
screening
primary care
validity
Hebrew
Primary care and general medical patients

Additional relevant MeSH terms:
Depression
Depressive Disorder
Behavioral Symptoms
Mood Disorders
Mental Disorders

ClinicalTrials.gov processed this record on September 18, 2014